Sharing our innovation at the Royal Society of Medicine

On Saturday 18th of April, the Micreos team presented at the Royal Society of Medicine (RSM) Spring Medical Innovation Summit in London. The summit was the latest in a series hosted by the RSM which, over the last 5 years, have involved over 150 innovators and entrepreneurs from across the world. The wide and varied pool of presenters is one of the highlights of these summits; over the years presentations have been made by doctors, architects, biomedical engineers, inventors and students, and the series aims to encourage cross-fertilisation of ideas between different disciplines, in order to foster innovation in the medical and healthcare sector.

It was a privilege to be invited to be part of the summit. We used our time to talk about the latest Staphefekt data in acne, eczema and rosacea, and to introduce the concept of the Colonisation-Infection Continuum. It was very encouraging to see everybody engaging in this concept, and we had some really good questions and fruitful discussions afterwards about the potential of endolysin technology as an antibiotic alternative.

It was great to hear about such a range of exciting new technologies and innovations. There were some truly memorable speakers, including Geraldine Hamilton from The Wyss Institute for Biologically Inspired Engineering at Harvard University who presented her ground-breaking ‘organs on chips’: USB-sized polymeric chips which are lined with human cells, recreating biological processes and emulating whole organs. A technology which has the potential to change the way we run clinical trials.

Another fantastic presentation was given by 16 year old Kenneth Shinozuka, whose device for Alzheimer’s sufferers (the SafeWander) alerts caregivers via their smart phone if a patient begins to wander at night. Currently, the system is undergoing beta testing at several residential care facilities. Kenneth came up with this concept when he was just 6 years old.

We see ourselves as pioneers of endolysin technology, but just as importantly, as collaborators. These ideologies are very closely aligned to those of the Medical Innovation Summit, and we will be keeping a close eye on our fellow innovators’ progress.